BIOMAT Database Logo BIOMAT Database Logo

Acute renal failure following sulfinpyrazone therapy. 1982

J J Scherrer, and J W Jackson, and O M Jerde

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013442 Sulfinpyrazone A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. Sulfoxyphenylpyrazolidin,Anturan,Anturane,Apo-Sulfinpyrazone,Nu-Sulfinpyrazone,Sulphinpyrazone,Apo Sulfinpyrazone,Nu Sulfinpyrazone
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

J J Scherrer, and J W Jackson, and O M Jerde
Sulfinpyrazone-associated acute renal failure.
July 1983, Clinical nephrology,
J J Scherrer, and J W Jackson, and O M Jerde
Abnormalities of urinary sediment and renal failure following sulfinpyrazone therapy.
September 1976, Archives of internal medicine,
J J Scherrer, and J W Jackson, and O M Jerde
Acute renal failure due to sulfinpyrazone.
May 1998, The American journal of the medical sciences,
J J Scherrer, and J W Jackson, and O M Jerde
Acute renal failure and treatment with sulfinpyrazone.
September 1983, Clinical nephrology,
J J Scherrer, and J W Jackson, and O M Jerde
Oliguric acute renal failure after treatment with sulfinpyrazone.
January 1983, Clinical nephrology,
J J Scherrer, and J W Jackson, and O M Jerde
[Acute renal failure induced by sulfinpyrazone (author's transl)].
January 1981, Nephrologie,
J J Scherrer, and J W Jackson, and O M Jerde
Non oliguric acute renal failure after treatment with sulfinpyrazone.
May 1982, Clinical nephrology,
J J Scherrer, and J W Jackson, and O M Jerde
Sulfinpyrazone induced uric acid urolithiasis with acute renal failure.
July 1981, Connecticut medicine,
J J Scherrer, and J W Jackson, and O M Jerde
Acute renal failure following immunoglobulin therapy.
January 1996, American journal of nephrology,
J J Scherrer, and J W Jackson, and O M Jerde
Acute renal failure secondary to sulfinpyrazone treatment after myocardial infarction.
January 1984, Nephron,
Copied contents to your clipboard!